BILL ANALYSIS Ó
SCR 26
Page 1
SENATE THIRD READING
SCR
26 (Beall)
As Introduced March 5, 2015
Majority vote
SENATE VOTE: 32-0
--------------------------------------------------------------------
|Committee |Votes |Ayes |Noes |
| | | | |
| | | | |
|----------------+------+---------------------+----------------------|
|Rules |11-0 |Gordon, Chang, | |
| | |Burke, Campos, | |
| | |Cooley, Dodd, Jones, | |
| | |Mayes, Rodriguez, | |
| | |Waldron, Wood | |
--------------------------------------------------------------------
SUMMARY: Proclaims November 2015 as Pancreatic Cancer Awareness
Month in California. Specifically, this resolution makes the
following legislative findings:
1)Pancreatic cancer is one of the deadliest cancers, is the fourth
leading cause of cancer death in the United States, and is the
only major cancer with a five-year relative survival rate in the
SCR 26
Page 2
single digits at just 7%.
2)Symptoms of pancreatic cancer usually first present themselves
in its late stage, and 72% of pancreatic cancer patients die
within the first year of their diagnosis, while 93% of
pancreatic cancer patients die within the first five years.
3)In 2015, an estimated 48,960 people will be diagnosed with
pancreatic cancer and 40,560 people will die from the disease in
the United States. The incidence and death rate for pancreatic
cancer are increasing, pancreatic cancer is anticipated to move
from the fourth to the second leading cause of cancer death in
the United States by 2020, and the number of deaths from the
disease will increase 2.4 fold by 2030.
4)The federal government invests significantly less money in
pancreatic cancer research than it does in research of any other
leading deadly cancer, constituting only approximately 2% of the
National Cancer Institute's research funding, a figure far too
low given the severity of the disease, its mortality rate, and
how little is known about how to arrest it.
5)The Pancreatic Cancer Action Network is a national organization
serving the pancreatic cancer community in California, where it
is headquartered, and nationwide through a comprehensive
approach, which includes public policy, research funding,
patient services, and public awareness and education related to
developing effective treatments and a cure for pancreatic
cancer.
FISCAL EFFECT: None
Analysis Prepared by:
Nicole Willis / RLS. / (916) 319-2800 FN:
0000164
SCR 26
Page 3